Remove 2022 Remove Protein Production Remove Regulations
article thumbnail

Advancements in upstream CLD for enhanced biotherapeutics production

Drug Discovery World

In addition, it has stimulated increased collaboration among drug developers, technology providers, supply chain organisations, and regulators. Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production. Budge JD, Knight TJ, Povey J, et al.

article thumbnail

Turning science into business: Amplifying mRNA by targeting regRNAs

Drug Discovery World

Recently, research published by Dr Richard (Rick) Young (Whitehead Institute) describes the key mechanism of how these regRNAs regulate gene expression. So, regRNAs haven’t been exploited previously because scientists have only recently understood their role in regulating gene expression. Can you give some examples?

Science 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Targeting a human protein may stop Ebola virus in its tracks

The Pharma Data

The researchers found that Ebola virus polymerase leverages host protein GSPT1 to positively regulate viral transcription – a process the virus uses to convert its genetic material into instructions for making viral proteins. Cell Reports, 2022. “We weren’t expecting to see this,” says Fang.

Virus 52
article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

BY RACHEL COE, MSC | APR 11, 2024 1:06 PM CDT Regulatory background: Product potency and assays As defined in statute , the FDA uses the term “potency” to refer to the “specific ability or capability” of a product to “effect a given result.” morphological cell changes or alterations in protein production or expression).

article thumbnail

World RNA Day: What impact RNA it had on drug discovery?  

Drug Discovery World

Also from Alnylam, in September 2022, the European Commission (EC) has granted marketing authorisation for the company’s AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis.

RNA 130
article thumbnail

Codon Digest: Bacteria Resist Every Virus

Codon

Self-regulating living material with temperature-dependent light absorption. Peroxisomal metabolic coupling improves fatty alcohol production from sole methanol in yeast. Optogenetic closed-loop feedback control of the unfolded protein response optimizes protein production. Nature Communications. Science Advances.

Virus 52
article thumbnail

Beyond Steel Tanks

Codon

In response to this hysteria, regulation was aggressively tightened. In 2012, an Israeli company called Protalix gained approval for their plant-based enzyme product for Gaucher’s disease. Kanuma, their FDA-approved protein product for rare lysosomal diseases, is “purified from the egg white of transgenic hens.”